Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Isabl Inc.

Isabl develops cancer diagnostic tests based on whole genome and RNA sequencing data.
2020
2-10
New York, New York, United States

Investment Funding

Last Funding Stage

Grant

Total Funding Amount

5.M

Last Funding Amount

2.M

Last Funding Date

01-04-2023

Startup Stage

Seed

Lead Investors

Y Combinator, Two Sigma Ventures, Sand Hill Angels, BoxOne Ventures, National Cancer Institute

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information